In2Bones Global

In2Bones USA and Invibio Announce R&D, Development and Manufacturing Agreement

Retrieved on: 
Tuesday, November 17, 2020
Health, Surgery, Medical Supplies, Medical devices, Chemistry, Textiles, Organic compounds, Victrex, Organic polymers, Polyethers, Thermoplastics, Polyether ether ketone, Peek, Biomaterial, Johnson Controls, Carbon fibers, In2Bones Global, Invibio Biomaterial Solutions, Victrex plc

In2Bones Global, Inc. , a leading global manufacturer of implants for the upper and lower extremities, today announced its subsidiary, In2Bones USA , has reached an exclusive agreement with Invibio Limited , Lancashire, UK, a pioneer in the development of PEEK biomaterial solutions, to commence a research, development, and manufacturing collaboration that will apply Invibios novel PEEK-OPTIMA Ultra Reinforced (POUR) carbon fiber technology to In2Bones lower extremity implants.

Key Points: 
  • In2Bones Global, Inc. , a leading global manufacturer of implants for the upper and lower extremities, today announced its subsidiary, In2Bones USA , has reached an exclusive agreement with Invibio Limited , Lancashire, UK, a pioneer in the development of PEEK biomaterial solutions, to commence a research, development, and manufacturing collaboration that will apply Invibios novel PEEK-OPTIMA Ultra Reinforced (POUR) carbon fiber technology to In2Bones lower extremity implants.
  • Over the course of the new, multi-year development agreement, both companies will make significant investments and share technical capabilities, intellectual property, marketing prowess, clinical data and labor.
  • The agreement is expected to deliver the first new products to In2Bones in 2021 with ongoing conversion of In2Bones plate families in the future.
  • INVIBIO, PEEK-OPTIMA, INVIBIO BIOMATERIAL SOLUTIONS are trademarks of Victrex plc or its group companies.